QLS5132 Combination Therapy in Advanced Solid Tumors

Clinical trial NCT07453394 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07453394
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Cancer (GC)Non-small Cell Lung Cancer (NSCLC)Endometrial Cancer Advanced Solid Tumors Ovarian Cancer

Start date: 2026-04-01
Primary completion: 2027-04-01
Enrollment: 626

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.